Internal medicine
Hypertension, diabetes, dyslipidemia, kidney and liver disease, infections, anticoagulation, hospital medicine and practice guidelines.
Published issues
- What's next in internal medicine — November 12, 2026
This edition gathers four dated milestones expected between November 2026 and the first quarter of 2027: two FDA decisions on cardiometabolic drugs (lorundrostat and CagriSema), a third on a 25 mg presentation of oral…
🎧 ListenAudio newscast · 4:42 min - Internal Medicine Bulletin — November 2, 2026
Colleagues: this issue covers October 3 to November 2, 2026. It was a month of large pragmatic trials with neutral results (early vasopressin in septic shock, aspirin in chronic kidney disease), a new guideline from the…
🎧 ListenAudio newscast · 6:21 min - What's next in internal medicine — October 12, 2026
This edition covers what is coming in internal medicine between November and December 2026: three late-breaking blocks at the American Heart Association Scientific Sessions (Chicago, November 7 and 9), a pending FDA…
🎧 ListenAudio newscast · 4:17 min - Monthly internal medicine bulletin — October 2, 2026
Colleagues: this issue covers September 2 to October 2, 2026, plus four items from the last days of August (32 to 34 days old) that earn their place: four trials from the European cardiology congress with direct…
🎧 ListenAudio newscast · 6:01 min - Monthly internal medicine bulletin — September 29, 2026
Period covered: August 30 to September 29, 2026. A month dominated by the European cardiology (Munich) and respiratory (Barcelona) congresses, two FDA approvals of direct interest to the internist, and a large negative…
🎧 ListenAudio newscast · 6:16 min